{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:11:53Z","timestamp":1790964713409,"version":"4.1.0"},"reference-count":171,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011597","name":"Penn State Cancer Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011597","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.bbamem.2015.03.034","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T15:20:09Z","timestamp":1428247209000},"page":"2747-2755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"PB","title":["Targeting ion channels for cancer therapy by repurposing the approved drugs"],"prefix":"10.1016","volume":"1848","author":[{"given":"Vijay Pralhad","family":"Kale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantu G.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2767-2929","authenticated-orcid":false,"given":"Manoj K.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamem.2015.03.034_bb0005","series-title":"Cancer Facts & Figures","author":"American Cancer Society","year":"2014"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0015","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molmed.2010.01.005","article-title":"Ion channels and the hallmarks of cancer","volume":"16","author":"Prevarskaya","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/CCO.0b013e32835b651e","article-title":"Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapy","volume":"25","author":"Hainaut","year":"2013","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/307465a0","article-title":"Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis?","volume":"307","author":"DeCoursey","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0035","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1093\/emboj\/18.20.5540","article-title":"Oncogenic potential of EAG K(+) channels","volume":"18","author":"Pardo","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0040","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood-2010-01-262691","article-title":"Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers","volume":"117","author":"Pillozzi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0045","doi-asserted-by":"crossref","first-page":"7343","DOI":"10.1158\/0008-5472.CAN-07-0107","article-title":"Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity","volume":"67","author":"Gomez-Varela","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-10-109","article-title":"Tumor cell-selective apoptosis induction through targeting of K(V)10.1 via bifunctional TRAIL antibody","volume":"10","author":"Hartung","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0055","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/embor.2008.75","article-title":"Ion channels: functional expression and therapeutic potential in cancer. Colloquium on ion channels and cancer","volume":"9","author":"Fraser","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cell.2014.02.052","article-title":"Water permeation drives tumor cell migration in confined microenvironments","volume":"157","author":"Stroka","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0075","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.drudis.2013.11.005","article-title":"Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines","volume":"19","author":"Jin","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0080","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1158\/2159-8290.CD-13-0183","article-title":"A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors","volume":"3","author":"Jahchan","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0085","doi-asserted-by":"crossref","first-page":"e1051","DOI":"10.1038\/cddis.2014.9","article-title":"DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information","volume":"5","author":"Amelio","year":"2014","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0090","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3332\/ecancer.2014.485","article-title":"The Repurposing Drugs in Oncology (ReDO) project","volume":"8","author":"Pantziarka","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001862","article-title":"The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics","volume":"3","author":"Huang","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrc3635","article-title":"The roles of K(+) channels in cancer","volume":"14","author":"Pardo","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0105","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/307465a0","article-title":"Voltage-gated K+ channels in human lymphocyte-T \u2014 a role in mitogenesis","volume":"307","author":"Decoursey","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00232-005-0776-1","article-title":"Role of voltage-gated potassium channels in cancer","volume":"205","author":"Pardo","year":"2005","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-4598-5-41","article-title":"Overexpression of Eag1 potassium channels in clinical tumours","volume":"5","author":"Hemmerlein","year":"2006","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0120","doi-asserted-by":"crossref","first-page":"C125","DOI":"10.1152\/ajpcell.00488.2003","article-title":"Functional and molecular identification of intermediate-conductance Ca(2+)-activated K(+) channels in breast cancer cells: association with cell cycle progression","volume":"287","author":"Ouadid-Ahidouch","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0125","first-page":"4843","article-title":"HERG K+ channel, a regulator of tumor cell apoptosis and proliferation","volume":"62","author":"Wang","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0130","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1200\/JCO.2005.05.4569","article-title":"Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma","volume":"24","author":"Mamelak","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0135","first-page":"582","article-title":"Overexpression of the G-protein inwardly rectifying potassium channel 1 (GIRK1) in primary breast carcinomas correlates with axillary lymph node metastasis","volume":"61","author":"Stringer","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0140","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2407-5-104","article-title":"Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines","volume":"5","author":"Plummer","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2407-4-93","article-title":"Expression of inwardly rectifying potassium channels (GIRKs) and beta-adrenergic regulation of breast cancer cell lines","volume":"4","author":"Plummer","year":"2004","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s002329900556","article-title":"An ATP-sensitive K+ current that regulates progression through early G1 phase of the cell cycle in MCF-7 human breast cancer cells","volume":"171","author":"Klimatcheva","year":"1999","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0155","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1158\/0008-5472.CAN-07-5163","article-title":"TREK-1 is a novel molecular target in prostate cancer","volume":"68","author":"Voloshyna","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1535-6108(03)00054-0","article-title":"Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene","volume":"3","author":"Mu","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0165","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s10495-007-0101-9","article-title":"Heat shock proteins and p53 play a critical role in K+ channel-mediated tumor cell proliferation and apoptosis","volume":"12","author":"Han","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11060-008-9517-5","article-title":"The two-pore domain potassium channel TASK3 functionally impacts glioma cell death","volume":"87","author":"Meuth","year":"2008","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0175","doi-asserted-by":"crossref","first-page":"36234","DOI":"10.1074\/jbc.M801830200","article-title":"Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors","volume":"283","author":"Downie","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0180","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/01.RES.87.6.496","article-title":"Expression and function of endothelial Ca2+-activated K+ channels in human mesenteric artery \u2014 a single-cell reverse transcriptase-polymerase chain reaction and electrophysiological study in situ","volume":"87","author":"Kohler","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0185","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-6-22","article-title":"Calcium-activated potassium channels mediated blood\u2013brain tumor barrier opening in a rat metastatic brain tumor model","volume":"6","author":"Hu","year":"2007","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0190","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000025606","article-title":"Blockade of Ca2+-activated K+ channels inhibits proliferation of human endothelial cells induced by basic fibroblast growth factor","volume":"35","author":"Wiecha","year":"1998","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0195","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1158\/0008-5472.CAN-03-2360","article-title":"herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells","volume":"64","author":"Lastraioli","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S1740925X06000044","article-title":"A role for ion channels in glioma cell invasion","volume":"2","author":"McFerrin","year":"2006","journal-title":"Neuron Glia Biol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0205","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1158\/1535-7163.MCT-06-0194","article-title":"Identification of SK3 channel as a new mediator of breast cancer cell migration","volume":"5","author":"Potier","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0210","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jcp.20434","article-title":"Subcellular distribution of calcium-sensitive potassium channels (IK1) in migrating cells","volume":"206","author":"Schwab","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0215","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00424-008-0452-2","article-title":"Activation of cell migration with fibroblast growth factor-2 requires calcium-sensitive potassium channels","volume":"456","author":"Kessler","year":"2008","journal-title":"Pflugers Arch. - Eur. J. Physiol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0220","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jcp.1041650121","article-title":"Changes in membrane-potential during the progression of Mcf-7 human mammary-tumor cells through the cell-cycle","volume":"165","author":"Wonderlin","year":"1995","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0225","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/(SICI)1097-4652(199809)176:3<456::AID-JCP2>3.0.CO;2-N","article-title":"Evidence for an early G1 ionic event necessary for cell cycle progression and survival in the MCF-7 human breast carcinoma cell line","volume":"176","author":"Wang","year":"1998","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0230","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/365560a0","article-title":"Cell-cycle control of a large-conductance K+ channel in mouse early embryos","volume":"365","author":"Day","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1083\/jcb.201404136","article-title":"Targeting potassium channels in cancer","volume":"206","author":"Huang","year":"2014","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0240","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0306-3623(95)00062-3","article-title":"Mitogenic signal transduction in human breast cancer cells","volume":"26","author":"Strobl","year":"1995","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0245","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jcp.1041620202","article-title":"Inhibition of Atp-sensitive potassium channels causes reversible cell-cycle arrest of human breast-cancer cells in tissue-culture","volume":"162","author":"Woodfork","year":"1995","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0250","doi-asserted-by":"crossref","first-page":"20130094","DOI":"10.1098\/rstb.2013.0094","article-title":"Potassium channels in cell cycle and cell proliferation","volume":"369","author":"Urrego","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0255","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002329900563","article-title":"Identification of ether a go\u2013go and calcium-activated potassium channels in human melanoma cells","volume":"171","author":"Meyer","year":"1999","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0260","doi-asserted-by":"crossref","first-page":"18528","DOI":"10.1074\/jbc.M200592200","article-title":"Functional up-regulation of HERG K+ channels in neoplastic hematopoietic cells","volume":"277","author":"Smith","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0265","article-title":"Ether a go\u2013go potassium channel expression in soft tissue sarcoma patients","volume":"5","author":"de Queiroz","year":"2006","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0270","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.1158\/0008-5472.CAN-04-1204","article-title":"Ether a go\u2013go potassium channels as human cervical cancer markers","volume":"64","author":"Farias","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0275","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.neulet.2004.07.001","article-title":"Expression of ether a go\u2013go potassium channels in human gliomas","volume":"368","author":"Patt","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0280","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1054\/bjoc.2000.1497","article-title":"HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium","volume":"83","author":"Cherubini","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0285","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1073\/pnas.0606702104","article-title":"SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5","volume":"104","author":"Benson","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"23","key":"10.1016\/j.bbamem.2015.03.034_bb0290","first-page":"10743","article-title":"One sumo is sufficient to silence the dimeric background potassium channel K2P1","volume":"107","author":"Plant","year":"2010","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0295","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1096\/fj.12-218230","article-title":"Regulation of ion channels by the serum- and glucocorticoid-inducible kinase SGK1","volume":"27","author":"Lang","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0300","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1096\/fj.12-214387","article-title":"Channel sialic acids limit hERG channel activity during the ventricular action potential","volume":"27","author":"Norring","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0305","doi-asserted-by":"crossref","first-page":"34028","DOI":"10.1074\/jbc.M105248200","article-title":"Glycosylation increases potassium channel stability and surface expression in mammalian cells","volume":"276","author":"Khanna","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0310","doi-asserted-by":"crossref","first-page":"H77","DOI":"10.1152\/ajpheart.00008.2002","article-title":"Role of glycosylation in cell surface expression and stability of HERG potassium channels","volume":"283","author":"Gong","year":"2002","journal-title":"Am. J. Physiol. Heart Circ."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0315","doi-asserted-by":"crossref","first-page":"8709","DOI":"10.1074\/jbc.R110.210005","article-title":"Ion channel regulation by protein palmitoylation","volume":"286","author":"Shipston","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0320","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1101\/gad.193789.112","article-title":"Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics","volume":"26","author":"Huang","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0325","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/aps.2013.6","article-title":"hERG channel function: beyond long QT","volume":"34","author":"Babcock","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0330","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2337\/diacare.1.3.189","article-title":"Sulfonylurea drugs: mechanism of antidiabetic action and therapeutic usefulness","volume":"1","author":"Lebovitz","year":"1978","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0335","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archinte.1980.00330150028009","article-title":"Verapamil. A new class of antiarrhythmic agents with a variety of beneficial cardiovascular effects","volume":"140","author":"Talano","year":"1980","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0340","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1528-1167.2011.03365.x","article-title":"The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy","volume":"53","author":"Gunthorpe","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0345","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.2337\/db13-0531","article-title":"Molecular mechanism of sulphonylurea block of K-ATP channels carrying mutations that impair ATP inhibition and cause neonatal diabetes","volume":"62","author":"Proks","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0350","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.RES.84.9.989","article-title":"Mechanism of block and identification of the verapamil binding domain to HERG potassium channels","volume":"84","author":"Zhang","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0355","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3892\/ijo.2012.1483","article-title":"Depolarization potentiates TRAIL-induced apoptosis in human melanoma cells: role for ATP-sensitive K+ channels and endoplasmic reticulum stress","volume":"41","author":"Suzuki","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0360","doi-asserted-by":"crossref","DOI":"10.1186\/2050-6511-14-6","article-title":"Glibenclamide inhibits cell growth by inducing G0\/G1 arrest in the human breast cancer cell line MDA-MB-231","volume":"14","author":"Nunez","year":"2013","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0365","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/sj.bjp.0703863","article-title":"The sulphonylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human lung cancer cells","volume":"132","author":"Payen","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0370","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.bcp.2008.09.009","article-title":"Glibenclamide exerts an antitumor activity through reactive oxygen species-c-jun NH(2)-terminal kinase pathway in human gastric cancer cell tine MGC-803","volume":"76","author":"Qian","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0375","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1124\/mol.59.6.1376","article-title":"Verapamil inhibits proliferation of LNCaP human prostate cancer cells influencing K+ channel gating","volume":"59","author":"Rybalchenko","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0380","first-page":"231","article-title":"Verapamil enhancement of antitumor effect of cis-diamminedichloroplatinum(II) in nude mouse-grown human neuroblastoma","volume":"47","author":"Ikeda","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0385","first-page":"3617","article-title":"Antiproliferative effect of verapamil alone on brain tumor cells in vitro","volume":"48","author":"Schmidt","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0390","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3892\/ijo.2013.2228","article-title":"Identification of KvLQT1 K+ channels as new regulators of non-small cell lung cancer cell proliferation and migration","volume":"44","author":"Girault","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0395","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1085\/jgp.200409041","article-title":"Mechanism of block of hEag1 K+ channels by imipramine and astemizole","volume":"124","author":"Garcia-Ferreiro","year":"2004","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0400","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/187152011795347513","article-title":"Astemizole: an old anti-histamine as a new promising anti-cancer drug","volume":"11","author":"Garcia-Quiroz","year":"2011","journal-title":"Anti Cancer Agents Med."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0405","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/IGC.0000000000000151","article-title":"Antiproliferative and proapoptotic effects of astemizole on cervical cancer cells","volume":"24","author":"Chavez-Lopez","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0410","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/S0006-3495(98)77727-6","article-title":"Imipramine inhibition of transient K+ current: an external open channel blocker preventing fast inactivation","volume":"75","author":"Kuo","year":"1998","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0415","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00232-001-0181-3","article-title":"Effects of imipramine on ion channels and proliferation of IGR1 melanoma cells","volume":"188","author":"Gavrilova-Ruch","year":"2002","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0420","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2867-11-6","article-title":"The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line","volume":"11","author":"Asher","year":"2011","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0425","doi-asserted-by":"crossref","DOI":"10.1186\/1423-0127-20-23","article-title":"Remodeling of calcium signaling in tumor progression","volume":"20","author":"Chen","year":"2013","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0430","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ceca.2004.07.002","article-title":"Variation of T-type calcium channel protein expression affects cell division of cultured tumor cells","volume":"37","author":"Panner","year":"2005","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0435","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-1-4020-6191-2_15","article-title":"Calcium signalling and cancer cell growth","volume":"45","author":"Capiod","year":"2007","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0440","first-page":"156","article-title":"Ion channels as targets for cancer therapy","volume":"3","author":"Li","year":"2011","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0445","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/er.2003-0008","article-title":"Regulation of cell cycle progression by calcium\/calmodulin-dependent pathways","volume":"24","author":"Kahl","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0450","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/01.RES.79.1.14","article-title":"Cell cycle-dependent expression of L- and T-Type Ca2+ currents in rat aortic smooth muscle cells in primary culture","volume":"79","author":"Kuga","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0455","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ceca.2006.04.029","article-title":"T-type calcium channels and tumor proliferation","volume":"40","author":"Panner","year":"2006","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0460","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/glia.20063","article-title":"Expression of T-type calcium channel splice variants in human glioma","volume":"48","author":"Latour","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0465","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0006-8993(92)90162-3","article-title":"Low-voltage-activated calcium channels in human retinoblastoma cells","volume":"598","author":"Barnes","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0470","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ceca.2007.03.006","article-title":"T-type Ca2+ channel expression in human esophageal carcinomas: a functional role in proliferation","volume":"43","author":"Lu","year":"2008","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0475","first-page":"4535","article-title":"Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5\u2032 CpG island in human tumors","volume":"59","author":"Toyota","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0480","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ceca.2004.05.001","article-title":"The role of voltage gated T-type Ca2+ channel isoforms in mediating \u201ccapacitative\u201d Ca2+ entry in cancer cells","volume":"36","author":"Gray","year":"2004","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0485","doi-asserted-by":"crossref","first-page":"10162","DOI":"10.1074\/jbc.M707159200","article-title":"CaV3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells","volume":"283","author":"Gackiere","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0490","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/0008-5472.CAN-03-3501","article-title":"Identification of channels promoting calcium spikes and waves in HT1080 tumor cells: their apparent roles in cell motility and invasion","volume":"64","author":"Huang","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0495","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.lfs.2008.01.008","article-title":"Endothelin-1 enhances proliferation of lung cancer cells by increasing intracellular free Ca2+","volume":"82","author":"Zhang","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0500","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bcp.2006.12.011","article-title":"G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells","volume":"73","author":"Yoshida","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0505","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1159\/000065266","article-title":"Broad antiproliferative effects of benidipine on cultured human mesangial cells in cell cycle phases","volume":"22","author":"Ono","year":"2002","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0510","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/j.bmcl.2012.09.076","article-title":"T-type Ca2+ channel blocker, KYS05047 induces G1 phase cell cycle arrest by decreasing intracellular Ca2+ levels in human lung adenocarcinoma A549 cells","volume":"22","author":"Rim","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0515","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/cdd.1984.1.353","article-title":"Calcium channel blocker enhancement of anticancer drug cytotoxicity\u2014a review","volume":"1","author":"Helson","year":"1984","journal-title":"Cancer Drug Deliv."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0520","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-3565(24)39245-6","article-title":"Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein","volume":"293","author":"Pauli-Magnus","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0525","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0735-1097(99)00447-7","article-title":"Calcium channel blockers, apoptosis and cancer: is there a biologic relationship?","volume":"34","author":"Mason","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0530","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/01.CIR.98.9.831","article-title":"Withdrawal of Posicor from market","volume":"98","author":"SoRelle","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0535","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1124\/dmd.107.020115","article-title":"The mibefradil derivative NNC55-0396, a specific T-type calcium channel antagonist, exhibits less CYP3A4 inhibition than mibefradil","volume":"36","author":"Bui","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0540","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1124\/mol.62.2.210","article-title":"The Ca2+ channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms","volume":"62","author":"Bertolesi","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0545","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2012-LB-76","article-title":"Abstract LB-76: mibefradil, a novel therapy for glioblastoma: an interlaced therapy approach","volume":"72","author":"Keir","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0550","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/bjc.1995.57","article-title":"Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells","volume":"71","author":"Kondo","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0555","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s10552-010-9590-x","article-title":"Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort","volume":"21","author":"Largent","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0560","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archinte.160.3.349","article-title":"Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer","volume":"160","author":"Meier","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0565","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jamainternmed.2013.9071","article-title":"Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years","volume":"173","author":"Li","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0570","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2165\/00003088-199630010-00003","article-title":"The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties","volume":"30","author":"Grundy","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0575","first-page":"2413","article-title":"Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse","volume":"52","author":"Taylor","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0580","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0090-3019(01)00444-X","article-title":"Calcium channel antagonists inhibit growth of subcutaneous xenograft meningiomas in nude mice","volume":"55","author":"Jensen","year":"2001","journal-title":"Surg. Neurol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0585","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1023\/A:1026556119020","article-title":"Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma","volume":"11","author":"Belpomme","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0590","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/bjc.1993.189","article-title":"Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study","volume":"67","author":"Millward","year":"1993","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0595","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(03)01831-4","article-title":"Antiproliferative effect of Ca2+ channel blockers on human epidermoid carcinoma A431 cells","volume":"472","author":"Yoshida","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0600","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/1097-0142(19950201)75:3<815::AID-CNCR2820750311>3.0.CO;2-R","article-title":"A phase-III randomized study of oral verapamil as a chemosensitizer to reverse drug-resistance in patients with refractory myeloma \u2014 a Southwest-Oncology-Group study","volume":"75","author":"Dalton","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0605","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s004320100289","article-title":"Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1\/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells","volume":"127","author":"Jull","year":"2001","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0610","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mce.2006.11.010","article-title":"FSH stimulates ovarian cancer cell growth by action on growth factor variant receptor","volume":"267","author":"Li","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0615","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1158\/0008-5472.CAN-05-0376","article-title":"Differential role of transient receptor potential channels in Ca2+ entry and proliferation of prostate cancer epithelial cells","volume":"66","author":"Thebault","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0620","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1038\/sj.onc.1210545","article-title":"TRPV6 channel controls prostate cancer cell proliferation via Ca2+\/NFAT-dependent pathways","volume":"26","author":"Lehen'kyi","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0625","doi-asserted-by":"crossref","first-page":"C493","DOI":"10.1152\/ajpcell.00624.2008","article-title":"Evidence that TRPM7 is required for breast cancer cell proliferation","volume":"297","author":"Guilbert","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0630","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1464-410X.2007.07293.x","article-title":"Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer","volume":"101","author":"Shabbir","year":"2008","journal-title":"BJU Int."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0635","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1464-410X.2007.07286.x","article-title":"Purinergic receptor-mediated effects of ATP in high-grade bladder cancer","volume":"101","author":"Shabbir","year":"2008","journal-title":"BJU Int."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0640","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1042\/BJ20060124","article-title":"Induced TRPC1 expression sensitizes intestinal epithelial cells to apoptosis by inhibiting NF-kappaB activation through Ca2+ influx","volume":"397","author":"Marasa","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0645","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1535-6108(02)00034-X","article-title":"Bcl-2-dependent modulation of Ca2+ homeostasis and store-operated channels in prostate cancer cells","volume":"1","author":"Vanden Abeele","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0650","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.cdd.4401375","article-title":"Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells","volume":"11","author":"Vanoverberghe","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0655","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbamcr.2007.01.001","article-title":"TRPV6 mediates capsaicin-induced apoptosis in gastric cancer cells\u2014mechanisms behind a possible new \u201chot\u201d cancer treatment","volume":"1773","author":"Chow","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0660","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1097-2765(01)00438-5","article-title":"LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death","volume":"9","author":"Hara","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0665","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1158\/0008-5472.CAN-03-3223","article-title":"Bcl-2-dependent modulation of swelling-activated Cl\u2212 current and ClC-3 expression in human prostate cancer epithelial cells","volume":"64","author":"Lemonnier","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0670","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1677\/erc.1.00898","article-title":"Alterations in the regulatory volume decrease (RVD) and swelling-activated Cl\u2212 current associated with neuroendocrine differentiation of prostate cancer epithelial cells","volume":"12","author":"Lemonnier","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0675","doi-asserted-by":"crossref","first-page":"L1339","DOI":"10.1152\/ajplung.00121.2007","article-title":"Involvement of chloride channels in TGF-beta1-induced apoptosis of human bronchial epithelial cells","volume":"293","author":"Cheng","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0680","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1158\/1535-7163.MCT-06-0475","article-title":"ClC-3 expression enhances etoposide resistance by increasing acidification of the late endocytic compartment","volume":"6","author":"Weylandt","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0685","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/abbi.2002.2762","article-title":"Calcium-mediated telomerase activity in ovarian epithelial cells","volume":"399","author":"Matte","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0690","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/157489206775246502","article-title":"Intracellular calcium, endothelial cells and angiogenesis","volume":"1","author":"Munaron","year":"2006","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0695","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc2403","article-title":"VEGF-targeted therapy: mechanisms of anti-tumour activity","volume":"8","author":"Ellis","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0700","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/01.ATV.0000231518.86795.0f","article-title":"VEGF activates receptor-operated cation channels in human microvascular endothelial cells","volume":"26","author":"Cheng","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0705","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.canlet.2009.03.023","article-title":"Critical role of TRPC6 channels in VEGF-mediated angiogenesis","volume":"283","author":"Ge","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0710","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-006-9281-1","article-title":"The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells","volume":"101","author":"Brackenbury","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0715","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.pcan.4500796","article-title":"A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo","volume":"8","author":"Diss","year":"2005","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0720","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ccr.2008.12.019","article-title":"Orai1 and STIM1 are critical for breast tumor cell migration and metastasis","volume":"15","author":"Yang","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0725","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ceca.2006.11.005","article-title":"A novel function of capsaicin-sensitive TRPV1 channels: involvement in cell migration","volume":"42","author":"Waning","year":"2007","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0730","first-page":"1515","article-title":"Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis","volume":"58","author":"Duncan","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0735","doi-asserted-by":"crossref","first-page":"24526","DOI":"10.1074\/jbc.M109.037390","article-title":"Knockdown of ASIC1 and epithelial sodium channel subunits inhibits glioblastoma whole cell current and cell migration","volume":"284","author":"Kapoor","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0740","doi-asserted-by":"crossref","first-page":"19220","DOI":"10.1074\/jbc.M603100200","article-title":"Surface expression of ASIC2 inhibits the amiloride-sensitive current and migration of glioma cells","volume":"281","author":"Vila-Carriles","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0745","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/jpet.108.142943","article-title":"Alpha conotoxin arenatus IB[V11l, V16D] is a potent and selective antagonist at rat and human native alpha 7 nicotinic acetylcholine receptors","volume":"327","author":"Innocent","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0750","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0006-8993(94)91610-1","article-title":"Alpha-bungarotoxin blocks the nicotinic receptor-mediated increase in cell number in a neuroendocrine cell-line","volume":"655","author":"Quik","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0755","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/1574892811308010066","article-title":"Persistent current blockers of voltage-gated sodium channels: a clinical opportunity for controlling metastatic disease","volume":"8","author":"Djamgoz","year":"2013","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0760","doi-asserted-by":"crossref","first-page":"10824","DOI":"10.1074\/jbc.M108754200","article-title":"Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells","volume":"277","author":"Mariot","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0765","first-page":"1002","article-title":"Inhibition of human prostate cancer proliferation in vitro and in a mouse model by a compound synthesized to block Ca2+ entry","volume":"60","author":"Haverstick","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0770","first-page":"35","article-title":"Identification of a new breast cancer-related gene by restriction landmark genomic scanning","volume":"26","author":"Asaga","year":"2006","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0775","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1523\/JNEUROSCI.22-02-00396.2002","article-title":"Differential inhibition of T-type calcium channels by neuroleptics","volume":"22","author":"Santi","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0780","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1016\/j.bmcl.2006.07.046","article-title":"Growth inhibition of human cancer cells in vitro by T-type calcium channel blockers","volume":"16","author":"Lee","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0785","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/pr.57.4.5","article-title":"International Union of Pharmacology. XLVIII. Nomenclature and structure\u2013function relationships of voltage-gated calcium channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0790","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1096\/fj.06-6200com","article-title":"Voltage-gated K+ channels support proliferation of colonic carcinoma cells","volume":"21","author":"Spitzner","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0795","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.4049\/jimmunol.158.11.5120","article-title":"Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo","volume":"158","author":"Koo","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0800","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0898-6568(90)90069-M","article-title":"Tamoxifen blocks both proliferation and voltage-dependent K+ channels of neuroblastoma-cells","volume":"2","author":"Rouzairedubois","year":"1990","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0805","first-page":"153","article-title":"Selective expression of HERG and Kv2 channels influences proliferation of uterine cancer cells","volume":"25","author":"Suzuki","year":"2004","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0810","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.4049\/jimmunol.156.4.1425","article-title":"T cell activation is regulated by voltage-dependent and calcium-activated potassium channels","volume":"156","author":"Rader","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0815","doi-asserted-by":"crossref","first-page":"C125","DOI":"10.1152\/ajpcell.00488.2003","article-title":"Functional and molecular identification of intermediate-conductance Ca2+-activated K+ channels in breast cancer cells: association with cell cycle progression","volume":"287","author":"Ouadid-Ahidouch","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0820","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jnr.20240","article-title":"Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells","volume":"78","author":"Weaver","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0825","doi-asserted-by":"crossref","first-page":"10917","DOI":"10.1073\/pnas.96.19.10917","article-title":"Inhibition of T cell proliferation by selective block of Ca(2+)-activated K(+) channels","volume":"96","author":"Jensen","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0830","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s002329900066","article-title":"K+ channels and the intracellular calcium signal in human melanoma cell proliferation","volume":"151","author":"LeppleWienhues","year":"1996","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0835","first-page":"165","article-title":"Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update","volume":"9","author":"Tsuji","year":"2013","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0840","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1677\/erc.1.00969","article-title":"Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement","volume":"12","author":"Bidaux","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0845","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1172\/JCI30168","article-title":"Prostate cell differentiation status determines transient receptor potential melastatin member 8 channel subcellular localization and function","volume":"117","author":"Bidaux","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0850","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrc2171","article-title":"Calcium and cancer: targeting Ca2+ transport","volume":"7","author":"Monteith","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbamem.2015.03.034_bb0855","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00210-004-0981-y","article-title":"Inhibition of TRPM2 channels by the antifungal agents clotrimazole and econazole","volume":"370","author":"Hill","year":"2004","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bbamem.2015.03.034_bb0860","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/jcp.22596","article-title":"ClC-3 is a main component of background chloride channels activated under isotonic conditions by autocrine ATP in nasopharyngeal carcinoma cells","volume":"226","author":"Yang","year":"2011","journal-title":"J. Cell. Physiol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273615001133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273615001133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T22:27:16Z","timestamp":1747866436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0005273615001133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":171,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0005273615001133"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamem.2015.03.034","relation":{},"ISSN":["0005-2736"],"issn-type":[{"value":"0005-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting ion channels for cancer therapy by repurposing the approved drugs","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Biomembranes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamem.2015.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}